Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes

Clinical trial NCT05597202 · UNKNOWN

Trial details

NCT number: NCT05597202
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2023-01-01
Primary completion: 2024-03-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.